The University of Florida Research Foundation, or UFRF, named 32 faculty members as UFRF professors for 2019-2022, among them is Rhonda Cooper-DeHoff, Pharm.D., M.S., an associate professor of pharmacotherapy and translational research. Cooper-DeHoff also has a joint appointment in the College of Medicine’s division of cardiovascular medicine. The UFRF recognition goes to faculty who have a distinguished current record of research and a strong research agenda that is likely to lead to continued distinction in their fields.
Cooper-DeHoff, who is also the associate director of the Center for Pharmacogenomics and Precision Medicine, will receive a three-year, $5,000 annual salary supplement and a one-time $3,000 grant to assist her research projects.
Cooper-Dehoff has an active, externally funded research program, and her work is currently supported by the Patient-Centered Outcomes Research Institute, or PCORI, the National Human Genome Research Institute/NIH and the Department of Defense. She has authored, or co-authored, 174 peer-reviewed research publications, with 76 publications in the last five years.
“The UFRF Professorships recognize our most innovative and productive faculty, the best examples of researchers and scholars who have helped UF claim its place as a top 10 public university,” said David Norton, UF’s vice president for research. “Key to this recognition is that it is based not just on what they have done in the past, but what they are expected to achieve in the future. These are faculty who we anticipate will continue to generate cutting-edge research well into the future.”